SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
SocialPicks Community
Exercise Credits: A Financial Incentive to Combat a Growing Health Epidemic
HWAY
|
|
|
-31.31%
in
40 days
(closed on 10/03/08)
<> Just as carbon credits were created out of the thin air to create a financial incentive to mitigate global warming through the reduction of greenhouse gas emissions; perhaps exercise credits should be considered as a new type of health commodity to combat the growing obesity epidemic in the United States and other developed countries. According to statistics [PDF] at the Centers for Disease Control and Prevention website [CDC.gov], only one state had a prevalence of obesity less than 20% last ye>...
|
Healthways Inc.
HWAY
|
|
|
-36.68%
in
469 days
The company’s market is disease management and in the current Salmonella/E-Coli environment it has strong potential for growth. Ranked at #60 in the Forbes list it has a 42% growth rate; a P/E Ratio of 23.08 and an EPS of $1.32 per share. It is currently trading off its projected 1 yr. target of $40.00 per share and is a premium at a discounted $30.39 per share. A covered call investing position for HWAY with August expiration currently has a potential return of 2.6% with 13.2% downside protection. <> <> <> <> <> <> <> Analysts' Recommendatio>>><><><>>>>><><><>>><><>>>><><>< />>><><><><>>>><><><>>>>>>>><><><><><><><>>>>><><><>>><><>>>><><><>>>><><><>< />< />>>><><><>>><><>>>><><><>>>><><><>< />< />>>><><><>>><><>>>><><><>>>><><><>< />< />>>><><><>>><><>>>><><><>>>><><><>< />< />>>><><><>>><><>>>><><><>>>><><><>< />< />>>><><><>>><><>>>><><><>>>><><><>< />>>>>>>...
|
From the Blogosphere
Health Benefit Providers Face Uncertain Future
|
|
|

The accompanying table (click to enlarge) contains 36 companies included in the ETF Innovators Health Benefit Providers Index. Many of the companies included in this index face an uncertain future with the prospect for healthcare reform threatening the profit margin of managed care companies; although the prospect for universal health insurance promises increased volumes as more Americans gain coverage.
The index contains retail pharmacies such as Rite Aid (RAD), pharmacy benefit managers such as MedcoHealth Solutions (MHS), managed care companies such as UnitedHealth (UNH), supplemental hea...
|
1-Year Analysis of Healthcare ETFs
|
|
|
 The accompanying table (click to enlarge) includes a summary and statistics for the 25 healthcare exchange-traded funds (ETFs) which are currently on the market. The group posted a 23.5% loss over the past year on an equal-weight basis with an average of about $400M in net assets. However, the top eight ETFs by net assets account for 88.5% of all net assets for the entire group of 25, including Healthcare Sector SPDR (XLV), Pharma HOLDRs (PPH), iShares Nasdaq Biotech (IBB), Biotech HOLDRs (BBH), iShares Dow Jones U.S. Healthcare (IYH), iShares S&P Global Healthcare (IXJ), Vanguard Healthcar...
|
New Preventive Medicine Index
|
|
|

One of the major reasons behind Pfizer's (PFE) interest in acquiring Wyeth (WYE) is the latter's focus on products outside of traditional pharmaceuticals – with 60% of Wyeth's revenue from last year derived from biological therapeutics and vaccines. It remains to be seen what happens to Wyeth's proposed deal to acquire Dutch vaccine maker Crucell (CRXL); however since it is much smaller (around $1B) and focuses on the development of vaccines, Pfizer would likely be interested in both companies together.
With the focus on preventive medicine likely continue in the form of continued M&A...
|
Analyst upgrades, downgrades and initiations: MET, COST, WAG, CAG...
Analyst upgrades, downgrades and initiations: MET, COST, WAG, CAG...
Filed under: Analyst reports, Analyst upgrades and downgrades, Analyst initiations Analyst upgrades:<> Keefe Bruyette upgraded MetLife (NYSE: MET) to Outperform from Market Perform as they believe the company's capital and liquidity profile are very solid relative to this week's sell-off. The firm also upgraded shares of MSCI (NYSE: MXB) to Outperform from Market Perform on valuation as they believe near-term challenges are already priced into shares. Burlington Northern (NYSE: BNI) was raised to Overweight from Neutral at JP Morgan based on valuation and strong pricing outlook. >...
|
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on HWAY |
Visit streetinsider.com
Be the first to start a discussion and earn 2 points.
More Resources
|